CD8A and neoplasm: In melanoma patients, innovative strategies such as fecal microbiota transplantation (FMT) combined with anti-PD-1 therapy have also been shown to be useful in overcoming resistance by modifying the gut microbiome, resulting in enhanced CD8+ T-cell activation within the tumor microenvironment.